Literature DB >> 32902691

Talar OsteoPeriostic grafting from the Iliac Crest (TOPIC) for large medial talar osteochondral defects : Operative technique.

G M M J Kerkhoffs1,2,3, J N Altink4,5,6, S A S Stufkens4,5,6, J Dahmen4,5,6.   

Abstract

OBJECTIVE: Provision of a natural scaffold, good quality cells, and growth factors in order to facilitate the replacement of the complete osteochondral unit with matching talar curvature for large medial primary and secondary osteochondral defects of the talus. INDICATIONS: Symptomatic primary and secondary medial osteochondral defects of the talus not responding to conservative treatment; anterior-posterior or medial-lateral diameter >10 mm on computed tomography (CT); closed distal tibial physis in young patients. CONTRAINDICATIONS: Tibiotalar osteoarthritis grade III; multiple osteochondral defects on the medial, central, and lateral talar dome; malignancy; active infectious ankle joint pathology. SURGICAL TECHNIQUE: A medial distal tibial osteotomy is performed, after which the osteochondral defect is excised in toto from the talar dome. The recipient site is microdrilled in order to disrupt subchondral bone vessels. Then, the autograft is harvested from the ipsilateral iliac crest with an oscillating saw, after which the graft is adjusted to an exact fitting shape to match the extracted osteochondral defect and the talar morphology as well as curvature. The graft is implanted with a press-fit technique after which the osteotomy is reduced with two 3.5 mm lag screws and the incision layers are closed. In cases of a large osteotomy, an additional third tubular buttress plate is added, or a third screw at the apex of the osteotomy. POSTOPERATIVE MANAGEMENT: Non-weight bearing cast for 6 weeks, followed by another 6 weeks with a walking boot. After 12 weeks, a CT scan is performed to assess consolidation of the osteotomy and the inserted autograft. The patient is referred to a physiotherapist.
RESULTS: Ten cases underwent the TOPIC procedure, and at 1 year follow-up all clinical scores improved. Radiological outcomes showed consolidation of all osteotomies and all inserted grafts showed consolidation. Complications included one spina iliaca anterior avulsion and one hypaesthesia of the saphenous nerve; in two patients the fixation screws of the medial malleolar osteotomy were removed.

Entities:  

Keywords:  Ankle; Cartilage regeneration; Iliac crest; Osteochondral autograft; Transplantation technique

Year:  2020        PMID: 32902691     DOI: 10.1007/s00064-020-00673-9

Source DB:  PubMed          Journal:  Oper Orthop Traumatol        ISSN: 0934-6694            Impact factor:   1.154


  48 in total

1.  Transchondral fractures (osteochondritis dissecans) of the talus.

Authors:  A L BERNDT; M HARTY
Journal:  J Bone Joint Surg Am       Date:  1959-09       Impact factor: 5.284

Review 2.  Complications following autologous bone graft harvesting from the iliac crest and using the RIA: a systematic review.

Authors:  Rozalia Dimitriou; George I Mataliotakis; Antonios G Angoules; Nikolaos K Kanakaris; Peter V Giannoudis
Journal:  Injury       Date:  2011-06-25       Impact factor: 2.586

3.  Bone-cartilage transplantation from the ipsilateral knee for chondral lesions of the talus.

Authors:  Axel W A Baltzer; Juergen P Arnold
Journal:  Arthroscopy       Date:  2005-02       Impact factor: 4.772

4.  Intermediate Results of Large Cystic Medial Osteochondral Lesions of the Talus Treated With Osteoperiosteal Cylinder Autografts From the Medial Tibia.

Authors:  Wan Chen; Kanglai Tang; Chengsong Yuan; You Zhou; Xu Tao
Journal:  Arthroscopy       Date:  2015-04-14       Impact factor: 4.772

5.  Osteochondral lesions of the talus: are there any differences between osteochondral and chondral types?

Authors:  Gi Won Choi; Woo Jin Choi; Hyun Kook Youn; Yoo Jung Park; Jin Woo Lee
Journal:  Am J Sports Med       Date:  2013-01-25       Impact factor: 6.202

6.  Surgical treatment of transchondral talar-dome fractures (osteochondritis dissecans). Long-term follow-up.

Authors:  A H Alexander; D M Lichtman
Journal:  J Bone Joint Surg Am       Date:  1980       Impact factor: 5.284

7.  Bone replaces articular cartilage in the rat knee joint after prolonged immobilization.

Authors:  T M Campbell; K Reilly; O Laneuville; H Uhthoff; G Trudel
Journal:  Bone       Date:  2017-09-30       Impact factor: 4.398

8.  Microfracture for osteochondral lesions of the ankle: outcome analysis and outcome predictors of 105 cases.

Authors:  Bavornrit Chuckpaiwong; Eric M Berkson; George H Theodore
Journal:  Arthroscopy       Date:  2007-11-19       Impact factor: 4.772

Review 9.  Biomaterials for articular cartilage tissue engineering: Learning from biology.

Authors:  A R Armiento; M J Stoddart; M Alini; D Eglin
Journal:  Acta Biomater       Date:  2017-11-08       Impact factor: 8.947

Review 10.  No superior treatment for primary osteochondral defects of the talus.

Authors:  Jari Dahmen; Kaj T A Lambers; Mikel L Reilingh; Christiaan J A van Bergen; Sjoerd A S Stufkens; Gino M M J Kerkhoffs
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-06-27       Impact factor: 4.342

View more
  3 in total

1.  [Osteochondral lesions of the talus : Individualized approach based on established and innovative reconstruction techniques].

Authors:  Christian David Weber; Gino Kerkhoffs; Jari Dahmen; Dari Ush Arbab; Philipp Kobbe; Frank Hildebrand; Philipp Lichte
Journal:  Unfallchirurg       Date:  2021-03-05       Impact factor: 1.000

2.  Clinical efficacy of the Ankle Spacer for the treatment of multiple secondary osteochondral lesions of the talus.

Authors:  Jari Dahmen; J Nienke Altink; Gwendolyn Vuurberg; Coen A Wijdicks; Sjoerd As Stufkens; Gino Mmj Kerkhoffs
Journal:  World J Orthop       Date:  2022-02-18

3.  Autologous matrix induced chondrogenesis (AMIC) as revision procedure for failed AMIC in recurrent symptomatic osteochondral defects of the talus.

Authors:  Filippo Migliorini; Hanno Schenker; Nicola Maffulli; Jörg Eschweiler; Philipp Lichte; Frank Hildebrand; Christian David Weber
Journal:  Sci Rep       Date:  2022-09-28       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.